These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2828199)

  • 1. Analysis of treatment failure in high-risk metastatic gestational trophoblastic disease.
    DuBeshter B; Berkowitz RS; Goldstein DP; Bernstein MR
    Gynecol Oncol; 1988 Feb; 29(2):199-207. PubMed ID: 2828199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The study and treatment of gestational trophoblastic diseases at the Brewer Trophoblastic Disease Center, 1962-1979.
    Lurain JR; Brewer JI
    Adv Exp Med Biol; 1984; 176():401-8. PubMed ID: 6093471
    [No Abstract]   [Full Text] [Related]  

  • 3. Metastatic gestational trophoblastic disease: prognostic factors in previously untreated patients.
    Soper JT; Clarke-Pearson D; Hammond CB
    Obstet Gynecol; 1988 Mar; 71(3 Pt 1):338-43. PubMed ID: 2831487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of metastatic trophoblastic disease with poor prognosis.
    Surwit EA; Hammond CB
    Obstet Gynecol; 1980 May; 55(5):565-70. PubMed ID: 6245395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
    Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
    J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for the prediction of treatment failure in gestational trophoblastic tumors treated with EMA/CO regimen.
    Kim SJ; Bae SN; Kim JH; Kim CJ; Jung JK
    Gynecol Oncol; 1998 Nov; 71(2):247-53. PubMed ID: 9826467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in gestational trophoblastic tumors: a proposed new scoring system based on multivariate analysis.
    Lurain JR; Casanova LA; Miller DS; Rademaker AW
    Am J Obstet Gynecol; 1991 Feb; 164(2):611-6. PubMed ID: 1847005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-risk metastatic gestational trophoblastic disease.
    Gordon AN; Gershenson DM; Copeland LJ; Saul PB; Kavanagh JJ; Edwards CL
    Obstet Gynecol; 1985 Apr; 65(4):550-6. PubMed ID: 2580255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choriocarcinoma following term gestation.
    Berkowitz RS; Goldstein DP; Bernstein MR
    Gynecol Oncol; 1984 Jan; 17(1):52-7. PubMed ID: 6319246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent chest opacity in trophoblastic disease: is thoracotomy justified?
    Wong LC; Ma HK
    Aust N Z J Obstet Gynaecol; 1983 Nov; 23(4):237-40. PubMed ID: 6324736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
    Homesley HD
    J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of chemotherapies with methotrexate, VP-16 and actinomycin-D in low-risk gestational trophoblastic disease. Remission rates and drug toxicities.
    Matsui H; Iitsuka Y; Seki K; Sekiya S
    Gynecol Obstet Invest; 1998; 46(1):5-8. PubMed ID: 9692333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary oral etoposide therapy in gestational trophoblastic disease. An update.
    Wong LC; Choo YC; Ma HK
    Cancer; 1986 Jul; 58(1):14-7. PubMed ID: 3011237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of prognostic factors in high risk gestational trophoblastic disease with respect to remission and recurrence].
    Matsui H; Kobayashi O; Takamizawa H
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Feb; 43(2):131-7. PubMed ID: 1849542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of multiagent chemotherapy and independent risk factors in the treatment of high-risk GTT--25 years experiences of KRI-TRD.
    Kim SJ; Bae SN; Kim JH; Kim CT; Han KT; Lee JM; Jung JK
    Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S85-96. PubMed ID: 9833620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vinblastine, cisplatin and bleomycin as salvage therapy for refractory high-risk metastatic gestational trophoblastic disease.
    DuBeshter B; Berkowitz RS; Goldstein DP; Bernstein M
    J Reprod Med; 1989 Mar; 34(3):189-92. PubMed ID: 2470902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy.
    Roberts JP; Lurain JR
    Am J Obstet Gynecol; 1996 Jun; 174(6):1917-23; discussion 1923-4. PubMed ID: 8678159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gestational trophoblastic tumors--a report of experiences].
    Ebeling K; Schönborn I; Johannsmeyer D
    Zentralbl Gynakol; 1995; 117(5):237-42. PubMed ID: 7540787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-risk factors in metastatic gestational trophoblastic neoplasia.
    DuBeshter B
    J Reprod Med; 1991 Jan; 36(1):9-13. PubMed ID: 1848903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gestational trophoblastic disease metastatic to the central nervous system.
    Evans AC; Soper JT; Clarke-Pearson DL; Berchuck A; Rodriguez GC; Hammond CB
    Gynecol Oncol; 1995 Nov; 59(2):226-30. PubMed ID: 7590478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.